Compare AVNS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNS | ABSI |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.7M | 461.6M |
| IPO Year | N/A | 2021 |
| Metric | AVNS | ABSI |
|---|---|---|
| Price | $11.84 | $3.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.78 |
| AVG Volume (30 Days) | 509.5K | ★ 5.0M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $699,900,000.00 | $2,815,000.00 |
| Revenue This Year | $3.07 | $10.72 |
| Revenue Next Year | $2.16 | $437.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.70 | N/A |
| 52 Week Low | $9.30 | $2.01 |
| 52 Week High | $18.91 | $6.33 |
| Indicator | AVNS | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 58.17 |
| Support Level | $11.05 | $3.36 |
| Resistance Level | $11.62 | $4.06 |
| Average True Range (ATR) | 0.43 | 0.25 |
| MACD | 0.03 | 0.11 |
| Stochastic Oscillator | 67.33 | 80.07 |
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.